- Filed
- Sep 29, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 3, 2025 | 79.12M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2024 | 77.02M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2024 | 69.59M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 60.99M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 60.13M sh |
| Stock Repurchased | Q2 2025 · Dec 31, 2024 | $12.59M |
| Stock Repurchased | Q2 2025 · Dec 31, 2024 | $12.59M |
| Stock Repurchased | Q2 2025 · Dec 31, 2023 | $198K |
| Stock Repurchased | Q2 2025 · Dec 31, 2023 | $198K |
| Capex | Q2 2025 · Dec 31, 2024 | $6.32M |
| Capex | Q2 2025 · Dec 31, 2024 | $10.28M |
| Capex | Q2 2025 · Dec 31, 2023 | $2.2M |
| Capex | Q2 2025 · Dec 31, 2023 | $5.01M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2024 | −$9.17M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2024 | −$13.3M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $583K |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $3.96M |
| Long Term Debt restated | Q2 2025 · Dec 31, 2024 | $68.9M |
| Long Term Debt restated | Q2 2025 · Jun 30, 2024 | $127.47M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $60.63M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $59.07M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2023 | $44.32M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $193.31M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $175.86M |
| Current Liabilities restated | Q2 2025 · Dec 31, 2024 | $238.55M |
| Current Liabilities restated | Q2 2025 · Jun 30, 2024 | $129.89M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $351.58M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $303.16M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $211.37M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $187.7M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $640.57M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $558.45M |
| Eps Diluted | Q2 2025 · Dec 31, 2024 | −$0.40 |
| Eps Diluted restated | Q2 2025 · Dec 31, 2024 | −$0.51 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.04 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.13 |
| Eps Basic | Q2 2025 · Dec 31, 2024 | −$0.40 |
| Eps Basic restated | Q2 2025 · Dec 31, 2024 | −$0.51 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.04 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.13 |
| Sga Expense restated | Q2 2025 · Dec 31, 2024 | $36.52M |
| Sga Expense restated | Q2 2025 · Dec 31, 2024 | $63.25M |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $21.51M |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $44.02M |
| Net Income restated | Q2 2025 · Dec 31, 2024 | −$32.13M |
| Net Income restated | Q2 2025 · Dec 31, 2024 | −$36.68M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$2.71M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$8.36M |
| Operating Income restated | Q2 2025 · Dec 31, 2024 | $777K |
| Operating Income restated | Q2 2025 · Dec 31, 2024 | $732K |
| Operating Income | Q2 2025 · Dec 31, 2023 | $2.27M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $2.5M |
| Cost Of Revenue restated | Q2 2025 · Dec 31, 2024 | $130.7M |
| Cost Of Revenue restated | Q2 2025 · Dec 31, 2024 | $249.61M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $114.27M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $221.76M |
| Revenue restated | Q2 2025 · Dec 31, 2024 | $176.22M |
| Revenue restated | Q2 2025 · Dec 31, 2024 | $329.78M |
| Revenue | Q2 2025 · Dec 31, 2023 | $143.89M |
| Revenue | Q2 2025 · Dec 31, 2023 | $279.98M |